LIVING DRUGS IN A BAG
NantKwest, Inc.
Mark For: LIVING DRUGS IN A BAG® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86705455 |
| Registration Number | 5130601 |
| Mark Literal Elements | LIVING DRUGS IN A BAG |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | May 12, 2016 |
| Current Location | PUBLICATION AND ISSUE SECTION 2017-01-24 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Alicia M. Passerin |
| Attorney Docket Number | NK-17 |
| Law Office Assigned | L30 |
| Employee Name | DYER, ERIN ZASKODA |
Timeline
| 2015-07-27 | Application Filed |
| 2016-01-00 | Date of First Use |
| 2016-01-01 | Date of First Use |
| 2016-01-01 | Date of Use In Commerce |
| 2016-05-12 | Amend to Register |
| 2017-01-24 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-01-24 | Status: Live/Registered |
| 2017-01-24 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2017-01-24 | Trademark Registered |
| 2018-07-08 | Transaction Date |
| 2022-01-24 | Maintenance Early File Date |
| 2023-01-24 | Maintenance On Time Date |
| 2023-07-24 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  NantKwest, Inc. |
| Address | 2533 South Coast Highway 101 The Plastino Building, Suite 210 Cardiff-by-the Sea, CALIFORNIA UNITED STATES 920072133 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2015-07-27 |
 TEAS RF New Application | MULTI | 2015-07-27 |
| XSearch Search Summary | XML | 2015-11-09 |
| XSearch Search Summary | XML | 2015-11-09 |
| Offc Action Outgoing | MULTI | 2015-11-12 |
| Amendment to Allege Use | MULTI | 2016-05-12 |
| Response to Office Action | MULTI | 2016-05-12 |
| Specimen | JPEG | 2016-05-12 |
| AAU Processing Complete | MULTI | 2016-05-14 |
| Amendment and Mail Process Complete | MULTI | 2016-05-14 |
| Offc Action Outgoing | MULTI | 2016-06-02 |
| Notation to File | XML | 2016-09-14 |
| Response to Office Action | MULTI | 2016-10-05 |
| Specimen | JPEG | 2016-10-05 |
| Amendment and Mail Process Complete | MULTI | 2016-10-21 |
| XSearch Search Summary | XML | 2016-11-08 |
| Accept-AAU-Notice | 2016-12-08 | |
| Notice of Acceptance of AAU | XML | 2016-12-09 |
| Examiners Amendment | XML | 2016-12-13 |
| Notation to File | XML | 2016-12-13 |
| Amendment and Mail Process Complete | MULTI | 2016-12-14 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2016-12-14 |
| Publication & Issue Review Complete | MULTI | 2016-12-21 |
| Registration Certificate | 2017-01-24 | |
| TEAS Rev, App and/or COA of Atty/Dom.Rep | MULTI | 2017-04-27 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes. FIRST USE: 20160100. FIRST USE IN COMMERCE: 20160100
IC 005. US 006 018 044 046 051 052. G & S: Cells for clinical, medical, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic purposes. FIRST USE: 20160100. FIRST USE IN COMMERCE: 20160100
IC 042. US 100 101. G & S: Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, therapeutics and research related thereto. FIRST USE: 20160100. FIRST USE IN COMMERCE: 20160100
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-04-27 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-04-27 | |
| REGISTERED-SUPPLEMENTAL REGISTER | 2017-01-24 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-12-20 | 69712 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-12-13 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2016-12-13 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2016-12-13 | 93001 |
| EXAMINER'S AMENDMENT ENTERED | 2016-12-13 | 88888 |
| APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2016-12-13 | |
| NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2016-12-09 | |
| USE AMENDMENT ACCEPTED | 2016-12-08 | 93001 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-10-20 | 69712 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-10-20 | 69712 |
| ASSIGNED TO LIE | 2016-10-14 | 69712 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-10-05 | |
| ASSIGNED TO EXAMINER | 2016-09-09 | 93001 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-06-02 | 6325 |
| NON-FINAL ACTION WRITTEN | 2016-06-02 | 76508 |
| NON-FINAL ACTION E-MAILED | 2016-06-02 | 6325 |
| USE AMENDMENT FILED | 2016-05-13 | 88889 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-05-13 | 88889 |
| AMENDMENT TO USE PROCESSING COMPLETE | 2016-05-13 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-05-12 | |
| TEAS AMENDMENT OF USE RECEIVED | 2016-05-12 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-05-12 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-11-12 | 6325 |
| NON-FINAL ACTION WRITTEN | 2015-11-12 | 76508 |
| NON-FINAL ACTION E-MAILED | 2015-11-12 | 6325 |
| ASSIGNED TO EXAMINER | 2015-11-05 | 76508 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-07-31 | |
| NEW APPLICATION ENTERED IN TRAM | 2015-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 